Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 3 (2006), Issue 12 (December)

1. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
   J Leukoc Biol, 80(6): 1262-71. [Abstract] [Full-text]
2. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.
   Clin Infect Dis, 44(1): 141-4. [Abstract] [Full-text]
3. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
   Clin Infect Dis, 44(1): 94-102. [Abstract] [Full-text]
4. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis.
   Clin Infect Dis, 44(1): 69-73. [Abstract] [Full-text]
5. Patients with previously treated tuberculosis no longer neglected.
   Clin Infect Dis, 44(1): 61-4. [Abstract] [Full-text]
6. Burden of tuberculosis in Serbia.
   Am J Infect Control, 34(10): 676-9. [Abstract] [Full-text]
7. Increase in tuberculin skin test converters among health care workers after a change from Tubersol to Aplisol.
   Am J Infect Control, 34(10): 651-4. [Abstract] [Full-text]
8. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
   Chest, 130(6): 1712-7. [Abstract] [Full-text]
9. Who puts the tubercle in tuberculosis?
   Nat Rev Microbiol, 5(1): 39-47. [Abstract] [Full-text]
10. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.
    Lancet, 368(9553): 2142-54. [Abstract] [Full-text]
11. Cloning, sequencing and expression of white rhinoceros (Ceratotherium simum) interferon-gamma (IFN-gamma) and the production of rhinoceros IFN-gamma specific antibodies.
    Vet Immunol Immunopathol, 115(1): 146-54. [Abstract] [Full-text]
12. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    J Med Chem, 49(26): 7854-60. [Abstract] [Full-text]
13. Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain.
    J Med Chem, 49(26): 7623-35. [Abstract] [Full-text]
14. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis.
    Infect Immun, 75(1): 527-30. [Abstract] [Full-text]
15. Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection.
    Infect Immun, 75(1): 523-6. [Abstract] [Full-text]
16. Unusual presentation of isolated sacral tuberculosis.
    Joint Bone Spine, 73(6): 751-2. [Abstract] [Full-text]
17. Costs and cost-effectiveness of adolescent compliance with treatment for latent tuberculosis infection: results from a randomized trial.
    J Adolesc Health, 40(1): 61-8. [Abstract] [Full-text]
18. Disseminated Mycobacterium tuberculosis infection due to interferon gamma deficiency. Response to replacement therapy.
    Thorax, 62(1): 97-9. [Abstract] [Full-text]
19. Coeliac disease and risk of tuberculosis: a population based cohort study.
    Thorax, 62(1): 23-8. [Abstract] [Full-text]
20. Viral gene expression in HIV transgenic mice is activated by Mycobacterium tuberculosis and suppressed after antimycobacterial chemotherapy.
    J Infect Dis, 195(2): 246-54. [Abstract] [Full-text]

© 2004-2008 Tuberculosis Research Today. All Rights Reserved.